About
John is an associate within our international capital markets and corporate groups.
He has experience representing issuers and underwriters in connection with equity and debt capital markets transactions, including Rule 144A and Regulation S offerings.
He speaks English and German.
Additional Information
- Advising SpaceX in relation to the European offering of its global IPO (2026)
- Advising Ottobock in relation to its IPO (2025)
- Advising STADA, Bain Capital and Cinven on the contemplated IPO of STADA (2025)
- Advising the underwriters on the IPO of Galderma Group AG on the SIX Swiss Stock Exchange (2024)
- Advising SCHOTT AG and SCHOTT Pharma AG & Co. KGaA on the IPO of SCHOTT Pharma AG & Co. KGaA (€935m) (2023)
- Advising the issuer ZF North America Capital and guarantor ZF Friedrichshafen on US dollar bonds (2023, 2024)
- Advising the initial purchasers in connection with Wepa Hygieneprodukte GmbH’s offerings of senior secured notes (2024, 2025)
John Haviland
Senior Associate
Frankfurt am Main Office
Große Gallusstraße 14
Frankfurt am Main 60315